Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Assets (2016 - 2025)

Historic Assets for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $90.0 billion.

  • Bristol Myers Squibb's Assets fell 276.99% to $90.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $90.0 billion, marking a year-over-year decrease of 276.99%. This contributed to the annual value of $90.0 billion for FY2025, which is 276.99% down from last year.
  • Bristol Myers Squibb's Assets amounted to $90.0 billion in Q4 2025, which was down 276.99% from $96.9 billion recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Assets ranged from a high of $112.4 billion in Q1 2021 and a low of $90.0 billion during Q4 2025
  • Moreover, its 5-year median value for Assets was $96.0 billion (2022), whereas its average is $98.5 billion.
  • As far as peak fluctuations go, Bristol Myers Squibb's Assets plummeted by 1349.12% in 2021, and later surged by 503.81% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Assets stood at $109.3 billion in 2021, then dropped by 11.43% to $96.8 billion in 2022, then dropped by 1.72% to $95.2 billion in 2023, then dropped by 2.69% to $92.6 billion in 2024, then fell by 2.77% to $90.0 billion in 2025.
  • Its Assets stands at $90.0 billion for Q4 2025, versus $96.9 billion for Q3 2025 and $94.7 billion for Q2 2025.